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Abstract
Background: NF-kB, a major transcription factor involved in mammalian inflammatory signaling, is primarily involved in
regulation of response to inflammatory cytokines and pathogens. Its levels are tightly regulated since uncontrolled
inflammatory response can cause serious diseases. Mathematical models have been useful in revealing the underlying
mechanisms, the dynamics, and other aspects of regulation in NF-kB signaling. The recognition that miRNAs are important
regulators of gene expression, and that a number of miRNAs target different components of the NF-kB network, motivate
the incorporation of miRNA regulated steps in existing mathematical models to help understand the quantitative aspects of
miRNA mediated regulation.
Methodology/Principal findings: In this study, two separate scenarios of miRNA regulation within an existing model are
considered. In the first, miRNAs target adaptor proteins involved in the synthesis of IKK that serves as the NF-kB activator. In
the second, miRNAs target different isoforms of IkB that act as NF-kB inhibitors. Simulations are carried out under two
different conditions: when all three isoforms of IkB are present (wild type), and when only one isoform (IkBa) is present
(knockout type). In both scenarios, oscillations in the NF-kB levels are observed and are found to be dependent on the levels
of miRNAs.
Conclusions/Significance: Computational modeling can provide fresh insights into intricate regulatory processes. The
introduction of miRNAs affects the dynamics of the NF-kB signaling pathway in a manner that depends on the role of the
target. This ‘‘fine-tuning’’ property of miRNAs helps to keep the system in check and prevents it from becoming
uncontrolled. The results are consistent with earlier experimental findings.
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Introduction
NF-kB plays a central role in inflammation and immune
response [1]. In the unstimulated state it is held inactive by the IkB
protein, while cellular stimulation with inflammatory agents results
in production of IKK. This mediates phosphorylation, ubiquitina-
tion and proteolysis of the IkB resulting in activation of NF-kB and
accumulation in the nucleus. Activated NF-kB is a transcription
factor that can bind the kB elements in target gene promoters and
regulate proinflammatory and immune response related genes [2].
Since misregulation of its levels can cause inflammatory diseases
and even cancer [1], the regulation of NF-kB levels is an
important mechanism by which development and differentiation
of the cells of the immune system are achieved (Figure 1).
The NF-kB pathway is regulated by a number of different
mechanisms, such as proteasome mediated degradation, tran-
scription regulation and phosphorylation. Two NF-kB proteins
p105 and p100 have long C-terminal domains that inhibit their
activity. On receiving appropriate signals active molecules are
generated by proteasome mediated cleavage [3,4]. In canonical
signaling, p105 is processed into active p50 but is held as a
heterodimer (with p65 or with c-Rel) by its interaction with the
IkB proteins. These proteins are phosphorylated by the IKK
complex which leads to their degradation mediated by protea-
somes, causing release of p50. p50 then moves into the nucleus
and activates transcription [5]. In non canonical signaling, p100 is
processed into active p52 through activation involving the kinase
NIK and IKKa mediated phosphorylation [6].
The canonical pathway is associated with inflammation and
innate immune response through stimulation of tumor necrosis
factor receptor (TNF) and Toll like receptor (TLR), while the non-
canonical pathway is associated with adaptive immunity, second-
ary lymphoid organs and B cell maturation, and is activated by
receptors such as LTbR, BAFF-R, CD40, and RANK [5]. Since
TNFa can also activate p100, a potential crosstalk also exists
between the two pathways [4]. Indeed it is believed that there is an
integrated signaling system involving NF-kB in different cells [4].
The static representation of a pathway cannot capture the
dynamics of regulation at a molecular level. Here mathematical
models that can quantitatively describe the temporal changes in
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both space and time and which have been refined by experimental
observations [7] have helped in developing a better understanding
of NF-kB signaling. Both stochastic and deterministic models have
been described in the literature and have been aimed at
understanding the mechanism of NF-kB activation through
stimulus-induced degradation of IkB [8], the different functions
of the three isoforms (IkBa, IkBb, IkBe) and their roles in different
NF-kB dynamics [9,10].
A major finding is the importance of IkBa (induced by NF-kB)
in providing a negative feedback leading to oscillations in NF-kB
levels in cells lacking other isoforms. The role of IkBb and IkBe is
to dampen the oscillations and when all the three isoforms are
present in the cell, the NF-kB response is biphasic [7].
Extracellular feedback loops arise in response to stimulation by
LPS (lipopolysaccharide) which activates two intracellular path-
ways that branch at the receptor level, dependent on MyD88 and
Trif [11]. The NF-kB activity is normally steady when both are
present but becomes oscillatory when either of the two is down-
regulated since both the pathways have the same activation
kinetics but have a 30 min gap in their activation time, causing
their oscillations to be out of phase. The sensitivity of NF-kB
dynamics to the timing and duration of IKK activity is also
demonstrated both by experimentation and modeling [12]. A
surge in IKK level resulting from TNFa stimulation generates a
transient NF-kB response, whereas a steady state IKK profile
resulting from LPS stimulation generates a sustained level of NF-
kB activity. Different IKK profiles cause activation of different
genes in response to TNFa and LPS stimulation [13].
Ihekwaba et al (2004) [14] constructed a NF-kB model
containing 64 parameters and 26 variables to which they applied
sensitivity analysis. Of these only eight reactions that involved
either IKK or IkBa as one of the components exerted a major
control on NF-kB oscillations. Hayot and Jayaprakash (2006) [15]
investigated cell-to-cell variability using a simplified version of the
Hoffman et al model [9]. They considered cellular NF-kB and
IKK as external parameters, and found intrinsic fluctuations to be
insignificant when these were fixed in a model with high level of
transcription. The extrinsic fluctuations, such as initial amount of
cellular NF-kB and amount of activated IKK were found to be
very significant.
Krishna et al (2006) [16] address two important questions
regarding NF-kB dynamics, on how the network produces
oscillations and how these oscillations are used to differentiate
among different stimuli and send specific signals to the
downstream genes. A small core network (three variable model)
has been studied and shown to produce ‘‘spiky oscillations’’ in
nuclear NF-kB concentrations. These spiky oscillations are robust
to changes in the parameters and are associated with an increased
Figure 1. TNFa signaling to NF-kB. NF-kB is held in the latent state in the cytoplasm by its inhibitor IkB. When TNFa binds to the TNF receptor
(TNFR), IkB kinase (IKK) gets activated and phosphorylates the inhibitor of NF-kB (IkB) that is subsequently ubiquitinated and degraded. The free NF-
kB enters the nucleus where it regulates the transcription of several genes. Among them is the gene for IkB that is up regulated by NF-kB. The
synthesized IkB, on binding to NF-kB, promotes its export to the cytoplasm and holds it in latent state thus forming a negative feedback loop.
doi:10.1371/journal.pone.0027774.g001
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sensitivity of the system to IKK, which is essential for differential
regulation of downstream genes.
MicroRNAs are a class of small RNAs involved in post-
transcriptional regulation [17]. They are typically about 22
nucleotides in length and are encoded from hairpin shaped
transcripts. In metazoans, they control gene expression and many
important cellular processes through translational repression and
exonucleolytic cleavage of their target mRNAs, by binding to their
39UTR. Similar to the TF’s (transcription factors) miRNAs are
trans-acting factors that exert their activity through composite cis-
regulatory elements that are encoded within the genomic DNA,
and act in a combinatorial manner and cooperatively on their
targets [18]. Since miRNAs are tightly linked to TF’s their
expression patterns are controlled by TF’s and vice versa. Cellular
regulation is likely to be a network involved in decision making
and miRNAs may be required as switches and fine tuners [19,20].
Recent studies have shown that miRNAs are also involved in
regulation of both innate and acquired immunity, particular via
the NF-kB pathway [21,22]. Specifically, miR146a, miR155,
miR-125b, miR-9 and miR-29 are known to be involved at
different steps in the NF-kB pathway. For instance, while the
expression of miR146a is dependent on NF-kB, it also regulates
genes that are involved in the NF-kB network [23,24]. miR-9 is
downregulated in ovarian cancers as compared to the normal
tissues, and it is also important in inhibiting ovarian cancer by
targeting the NF-kB1 mRNA [25]. In myoblasts, expression of
miR-29 is repressed by NF-kB through YY1 and polycomb
proteins. It serves as a tumor suppressor, since reconstitution of the
miRNA inhibits tumor growth and promotes differentiation [26].
Another instance of such regulation comes from the observation
that a cluster of 14 miRNAs from the virus KSHV genome
regulates the NF-kB pathway by reducing expression of IkBa
protein. Deletion of this cluster from the KSHV genome
significantly enhances viral lytic replication as a result of reduced
NF-kB activity whereas its expression has an opposite effect. This
suggests that the KSHV miRNAs are crucial in regulation of viral
latency and lytic replication by manipulation of the host survival
pathway [27].
A recent review [28] highlights the convergence of miRNAs and
NF-kB signalling. The functions of a handful of miRNAs such as
miR-146, miR-155, miR-181b, miR-21, miR-301a in the NF-kB
system have been discussed in detail, with exclusive emphasis on
the feedback loops they are involved in. The miR-146 is induced
by NF-kB and in turn negatively regulates IRAK1/TRAF6,
constituting a negative feedback loop. MiR-155 is also an NF-kB
transactivational target and is involved in a negative feedback loop
through regulation of IKK. miR-181b (activated by STAT3), has
recently been identified as involved in a positive feedback loop by
inhibiting CYLD (negative regulator of NF-kB), which in turn
causes increased NF-kB, that completes the loop by leading to
STAT3 activation. miR-21 and miR-301 are also known to be
involved in a positive feed back loop, by inhibiting genes (PTEN
and NKRF respectively) that are negative regulators of NF-kB,
and in turn, on activation of NF-kB, themselves get transcribed
Thus a range of studies have clearly shown the importance of
miRNAs in the regulation of the NF-kB network. In this work an
attempt is made to understand the role of miRNAs in NF-kB
system using mathematical models. Two different targets of
miRNAs, IKK and IkB’s are considered: these are known to be
the most important components that reflect the dominant
dynamics of the pathway [14,15]. Our results clearly show that
miRNAs can indeed change the dynamic properties of the NF-kB
network in a manner that is consistent with that observed during
immune response.
Results
Scenario 1: NF-kB induced miRNAs target the adaptor
proteins needed for the production of IKK
A few miRNAs, such as miR-146 (a, b) and miR-155 are known
to target and down-regulate adaptor proteins IRAK1 and TRAF6.
Down-regulation of the adaptor proteins causes a reduction in the
IKK levels that is essential for activating NF-kB. Unregulated
inflammatory response due to infections by pathogens is harmful
unless controlled through negative regulation and most known
attenuation mechanisms of inflammation involve negative tran-
scriptional feedback loops such as IkB and A20. Adding miRNAs
to the list of potential negative regulators of inflammation would
provide an improved understanding of immune regulation [23]. In
order to test this aspect and to understand the mechanisms of
participation of miRNAs in the NF-kB system, miRNA regulated
steps were included in the existing model, and the adaptors
producing IKK were considered as targets of the miRNAs. The
model proposed by Hoffman et al [9] is shown in Figure 1. Of the
three isoforms of IkB, when only IkBa is allowed to be expressed
and others are knocked out, NFkB levels oscillate, consistent with
the original model, though a biphasic curve is obtained with all
three isoforms of IkB.
The NF-kB induced miRNA negatively regulates the adapter
proteins TRAF6/IRAK1, thereby controlling IKK levels
(Figure 2). The set of relations used to describe the different steps
involving miRNA is given below. Briefly, once the pre-miRNA is
synthesized, Dicer processing of the pre-miRNA occurs, involving
the unwinding of the duplex followed by incorporation of only one
strand into the miRISC, the multiprotein complex that uses the
miRNA as a template for recognizing the target (complementary)
mRNA.
Figure 2. Scenario 1. IRAK1 and TRAF6 are adaptor proteins
producing IKK that frees the NF-kB from inhibition by IkB. The NF-kB
induced miRNA, targets the IRAK1/TRAF6 mRNA. The sign ‘‘+’’ indicates
activation whereas the sign ‘‘-‘‘indicates repression.
doi:10.1371/journal.pone.0027774.g002
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MiRNAs associate with their targets by base-pair complemen-
tarity. In plants, miRNAs show nearly perfect complementarity to
their target sequences generally located in the coding regions or 39
untranslated regions (39 UTR) of the mRNA. The perfect base
pairing triggers mRNA degradation. In animals, miRNAs regulate
gene expression by base pairing imperfectly to the 39 UTRs of the
target mRNA and inhibiting protein synthesis or causing mRNA
degradation. One major feature of animal miRNA-mRNA
interactions are the contiguous pairing in the miRNA 59 seed
region (commonly positions 2–8) and lack of complementarity in
the central region. The deciding factor between miRNA induced
mRNA degradation and miRNA induced translational repression,
is the extent of complementarity and presence of central matches
between the miRNA and its target [29,30].
The repressed mRNAs accumulate in P-bodies or GW bodies
[31], that serve as sites of translational repression and mRNA
decay and are enriched in factors that are involved in these
pathways. Most importantly, this process can be reversed,
indicating that P-bodies can serve as temporary storage sites for
mRNAs not participating in protein synthesis. This reversal of
repression causing the release of the repressed mRNA occurs
under specific conditions related to environmental stress [32] or
developmental cues [33].
Based on the mechanisms of miRNA action two cases were
considered [34]: Case 1: Degradation of the target mRNA in the
RISC (non-reversible miRNA mediated repression), Case 2:
Regeneration of the target mRNA from the RISC (reversible
miRNA mediated repression).
w
c1 miRNA ð1Þ
NF{kB
tr2 miRNA ð2Þ
miRNA
c2 w ð3Þ
miRISCz T arg et (TRAF6=IRAK1)
c3 CRISC ð4Þ
CRISC
c4 w (Case 1) ð5Þ
CRISC
c5 miRNAzT arg et (TRAF6=IRAK1) (Case 2) ð6Þ
w ~ (Source=Sink)
Equations 1, 2 imply the introduction of miRNA into the system
through constitutive transcription (c1) and also through NF-kB
induced transcription (tr2). The equation 3 represents the
degradation of miRNA at a constant rate (c2). Equation 4 (c3) is
a simplistic form of representing the entire process right from the
incorporation of a single stranded mature miRNA into the RISC
to give miRISC, which binds to the target mRNA forming a
miRNA:mRNA duplex in the RISC (CRISC). Equation 5,
governed by the rate constant c4 denotes the degradation of the
target mRNA in the RISC, whereas the Equation 6, with the rate
constant c5 denotes an alternative channel that may be operative
in some cases where due to certain environmental or develop-
mental conditions the RISC releases the target mRNA back to the
pool. The ratio between Equation 5 and 6 depends on the extent
of complementarity between the miRNA and its target sequence as
mentioned before.
A. Wild Type system. The biphasic plot characteristic of the
wild type becomes oscillatory with increase in the values of all the
parameters: c1, c3, and c4 or c5. Here, c1, c3 describe the
production (c1) (varied from 0.01 to 0.1 min
21) and binding (c3)
(varied from 0.001 to 0.01 min21) rates respectively. For Case 1,
c4 (varied from 0.001 to 0.01 min
21) represents the mRNA
degradation rate in the RISC; for Case 2, c5 (varied from 0.001 to
0.01 min21) denotes the mRNA regeneration rate from the RISC.
Moreover, as the levels of the parameters were increased, the
frequencies as well as the amplitude of the oscillations were found
to decrease significantly (Figure 3A, 3B). However, for Case 2
(Figure 3B), the changes in oscillatory behavior, such as decrease
in amplitude, was observed to be less dramatic than Case 1
(Figure 3A) on increasing the rate constants. Since the numbers of
oscillations produced on introduction of miRNAs were too few to
be quantified, the numbers of peaks were counted for indicating
the change in frequency; also decrease in the height of the first
peak, was taken as a measure of the negative potential of the
miRNAs in the system. The minimum level of the parameters did
not show much change among the two cases. The number of peaks
at increasing levels of the three miRNA related parameters (as
given in the figure legend), were two (blue line), one (pink line),
none (cyan and yellow) as compared to three, two and one at the
same levels in Case 2 (Figure 3A, 3B).
The height of the first peak, a measure of the peak NFkB
concentration, decreased much more sharply in Case 1 than in
Case 2. The average decrease of the peak for Case 1 was twice that
for Case 2 (Figure 3C).
The contribution of each of the parameters in the Wild type was
determined by varying one and keeping the other two constant.
Variation of the c1 parameter (from 0.01 to 1.00 min
21, keeping
c3 at 0.001 min
21 and c4/c5 at 0.001 min
21, and variation of the
c3 parameter (from 0.001 to 0.01 min
21), keeping c1 and c4/c5 at
0.01 min21 and at 0.001 min21 respectively, brought about a
decrease in the frequency and amplitude (Figures S1A, B, C, D).
Case 1 showed a sharper decrease as compared to Case 2 (Figures
S2A, B). Variation in the c4 and c5 parameter from 0.001 to
0.01 min21, keeping c1 at 0.01 min
21 and c3 at 0.01 min
21 in
Case 1 and Case 2 respectively, showed an interesting behavior
(Figures S1E, F). While both cases showed a sharp decrease in the
height of the first peak (from 0.056 to 0.023 in Case 1 and to 0.028
in Case 2) when miRNA was introduced in the model, an increase
in c4 did not have any effect on the height in Case 1 beyond that.
The Case 2, however, showed an increase in peak height with an
increase in c5 (average slope being 0.94). This is presumably
because a higher c5 in this case results in higher levels of
translatable mRNA being released from the RISC complex. This
explains the reason behind the prolonged oscillations and marginal
changes in the amplitude in Case 2 causing the overall differences
in the behaviour of the system in the two cases (Figure S2C).
B. Knockout Type System. Introduction of miRNAs in the
system wherein the IkBb and IkBe isoforms were knocked down
leaving only the IkBa isoform, reduced the frequency as well as the
amplitude of the pre-existing oscillations. The parameters were
increased in a similar manner as done for the wild type system. A
prolonged response was also noticed in this system, when mRNA
(target) and miRNAs were allowed back to the pool from the RISC
(Case 2) (Figure 4B) in comparison to the Case 1 (Figure 4A).
Modulation of the NF-kB Pathway by microRNAs
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The minimum level of the parameters did not show much
change among the two cases. The decrease in the frequency and
height of the first peak was taken as a measure of the negative
potential of the miRNA in the system.
The frequency showed different patterns for the two cases
(Figure 4C). In Case 1, the frequency decreased steadily
(slope = 0.001) as the parameter levels were increased, up to level
4, after which the oscillations stopped. In Case 2, however, the
frequency stayed nearly constant (at around 0.005, which was
actually higher than 0.0033, the frequency without the introduc-
tion of miRNA into the model) till the parameters were increased
to level 4, after which it steadily decreased (slope= 0.00215).
Similarly, as shown in Figure 4D, while the height of the first
peak fell sharply (and linearly) in Case 1, with a decrease of about
(0.03375) units per increase of parameter level before vanishing at
level 4, this fall was non-linear, and shallower for Case 2 (an
average fall of (0.01425).
The contribution of each of the miRNA parameters in the
Knockout type was determined by varying one and keeping the
other two constant, as described in the previous section for the Wild
type. Variation of the c1 parameter (from 0.01 to 1.00 min
21),
keeping c3 at 0.001 min
21 and c4/c5 at 0.001 min
21 and variation
in the c3 parameter (from 0.001 to 0.01 min
21), keeping c1 and c4/c5
at 0.01 min21 and at 0.001 min21 respectively, brought about a
sharp decrease in frequency and amplitude in both the cases. (See
Figures S3A, B, C, D and S4A, B, C, D)
Variation of the c4 parameter and c5 parameter (from 0.001 to
0.01 min21) in Case 1 and 2 respectively, keeping c1 at
0.01 min21 and c3 at 0.01 min
21, showed a striking behavior
(Figures S3E, F). While the frequency reduced to 0.0007 in Case 1,
it increased from 0.002 to 0.005 in Case 2 as c5 was increased up
to 0.003, staying constant thereafter (Figure S4E). The height of
the first peak also showed an increase (slope = 0.5) in Case 2, while
it remained at 0.032 in Case 1, showing no variation as c4 was
varied between 0.001 and 0.01. (See Figure S4F).
The findings can therefore be restated: the role of c1 and c3
parameters is to reduce the level of NFkB, in both the cases. The
parameter c5 is the one responsible for the prolonged oscillations
and higher amplitude and frequency in Case 2 as compared to
Case 1.
Scenario 2: miRNAs target the IkB isoforms
The IkB isoforms have important roles as inhibitors of NF-kB,
holding it in the latent state. It has been seen that some miRNAs
Figure 3. Effect of miRNA targeting the IRAK1/TRAF6 complex in the wild type. The miRNA parameters c1, c3 and c4 or c5 were varied,
keeping c2 at 0.00048 min
21. A) Case 1 B) Case 2. The colored lines in the figure represent the effect at varying levels of the three miRNA parameters.
The parameter values in parenthesis are c1, c3, c4/c5 respectively: Red (0.00, 0.000, 0.000) Green (0.01, 0.001, 0.001), Blue (0.03, 0.003, 0.003), Pink (0.05,
0.005, 0.005), Cyan (0.07, 0.007, 0.007), Yellow (0.10, 0.010, 0.010). In the y-axis title ‘‘NF-kappaBn’’, the ‘‘n’’ stands for nuclear. The Quantification was
done in terms of C) Alteration in the height of the first peak. This Figure section is derived from sections A, B. The x-axis signifies the 6 levels of
variation of the three parameters as given in sections A, B. The Brown and Black lines represent Cases 1 and 2 respectively.
doi:10.1371/journal.pone.0027774.g003
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or miRNA clusters target these IkB’s, and are therefore involved
in regulating the NF-kB pathway. Deletion of these miRNAs
from the Kaposi’s sarcoma-associated herpes virus genome
(KSHV) enhances viral lytic replication as a result of reduced
NF-kB activity. Thus, KSHV encodes miRNAs to control viral
replication by activating the NF-kB pathway. These results
illustrate an important role for KSHV miRNAs in regulating viral
latency and lytic replication by manipulating a host survival
pathway [27].
Here miRNA negatively regulates the IkB’s that hold the NF-
kB in latent state (Figure 5). The set of relations used to describe
different steps involving miRNA is described below. Here again
two Cases of miRNA action were considered: Case 1: Degradation
of the target mRNA in the RISC, Case 2: Regeneration of the
target mRNA from the RISC.
w
c1 miRNA ð7Þ
miRNA
c2 q ð8Þ
miRISCz T arg et (IkB)
c3 CRISC ð9Þ
CRISC
c4 w (Case 1) ð10Þ
CRISC
c5 miRNAzT arg et (IkB) (Case 2) ð11Þ
w~ (Source=Sink)
Equation 7 represents the introduction of miRNA into the
system through constitutive transcription (c1) only. The equation 8
represents the degradation of miRNA at a constant rate (c2).
Equation 9 (c3) is a simplistic form of representing the entire
process right from the incorporation of a single stranded mature
miRNA into the RISC to give miRISC, which binds to the target
Figure 4. Effect of miRNA targeting the IRAK1/TRAF6 complex in the knockout type. The miRNA parameters c1, c3 and c4 or c5 were varied,
keeping c2 at 0.00048 min
21. A) Case 1 B) Case 2. The colored lines in the figure represent the effect at varying levels of the three miRNA parameters.
The parameter values in parenthesis are c1, c3, c4/c5 respectively: Red (0.00, 0.000, 0.000), Green (0.01, 0.001, 0.001), Blue (0.03, 0.003, 0.003), Pink (0.05,
0.005, 0.005), Cyan (0.07, 0.007, 0.007), Yellow (0.10, 0.010, 0.010). In the y-axis title ‘‘NF-kappaBn’’, the ‘‘n’’ stands for nuclear. The Quantification was
done in terms of: C) Alteration in frequency D) Alteration in the height of the first peak. Figure sections C, D are derived from sections A, B. The x-axis
signifies the 6 levels of variation of the three parameters as given in sections A, B. The Brown and Black lines represent Cases 1 and 2 respectively.
doi:10.1371/journal.pone.0027774.g004
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mRNA (here the IkB’s) forming a miRNA:mRNA duplex in the
RISC (CRISC). Equation 10, governed by the rate constant c4
denotes the degradation of the target mRNA in the RISC, whereas
the Equation 11, with the rate constant c5 denotes an alternative
channel that may be operative in some cases where due to certain
environmental conditions the RISC releases the target mRNA
back to the pool.
Individual, as well as combinations of IkB’s were analyzed as
miRNA targets. Striking types of behaviour patterns on increasing
the miRNA related parameters such as the production (c1) (from
0.01 to 0.1 min21), binding (c3) (from 0.001 to 0.01 min
21) and
RISC degradation rates (c4/c5) (from 0.0001 to 0.001 min
21) all
together, keeping c2 constant at 0.00048 min
21 were noticed.
A) Distortion or no change in the biphasic behavior of the
wild type. In the following target assumptions, except for IkBe,
the biphasic plot gets distorted making the effect immeasurable.
When IkBe is the target, there occurs no change in the dynamics
(Figure S5):
Only IkBa as target
Only IkBe, as target
IkBa and IkBb as target
IkBa and IkBe, as target
All the three IkB’s as target
B) Conversion from the biphasic to oscillatory
behavior. In the following two target assumptions, a drastic
change in the behaviour was noticed. Firstly, the initial biphasic
became oscillatory similar to the knockout type behaviour.
Secondly, with the increase in the miRNA related parameters,
the frequency and amplitude of the oscillations increased.
When only IkBb was considered as the target (Figure 6A, 6B):
The positive role of the miRNA was measured in terms of both,
the frequency and the height of the first peak. The frequency
increased from 0.002 to 0.003 in Case 1 and 0.001 to 0.003 in
Case 2 (Figure 6C). The height of the first peak increased from
0.075 to 0.093 in Case 1 and 0.070 to 0.087 in Case 2 when only
IkBb was the target (Figure 6D). Figure 6C shows that the
frequency increased faster in Case 1, increasing from 0.002 to
0.003 as the parameters was increased to level 3, keeping constant
at higher levels; Case 2 showed average increases of 0.000425 per
level as miRNA parameter levels were varied between 2 and 6.
The height of the first peak increased relatively similarly (slopes
0.0045 and 0.0046 for Cases 1 and 2, respectively) between
parameter levels 2 and 6 (Figure 6D).
When both IkBb and IkBe were considered as targets
(Figure 7A, 7B): In contrast, the level of enhancement of frequency
when both IkBb and IkBe, were targeted (Figure 7C) was not
discernible (both increased from 0.001 to 0.003 as the parameter
levels were increased from 2 to 6). The height of the first peak also
increased almost exactly in same manner for the two cases
(Figure 7D), though Case 2 seemed to show slower increase at
higher levels of parameters (slope for Case 2 is 0.009 between
levels 4 and 6, while it is 0.01 for Case 1).
Discussion
The importance of miRNAs in gene regulatory networks is
becoming clearer with the discovery of a large number of miRNAs
that target almost the entire transcriptome. miRNAs alter the
network features of gene regulatory modules by targeting key
molecules and thus control many of the cellular decision making
systems [35]. The quantitative features and dynamics of the effect
of miRNAs in pathways and networks have not however been
adequately addressed. In this paper we have studied miRNA
mediated dynamics of a regulatory system through computational
modeling and simulation. The NF-kB pathway was chosen in part
since it has been extensively studied both experimentally and via
modeling and further, miRNAs are known to affect the regulation.
The existing mathematical model was suitably modified by
incorporation of miRNAs that target two major entities (IKK,
IkB’s) involved in the most sensitive dynamics of the pathway. The
two conditions were studied by considering two separate scenarios.
miRNAs target the adaptor proteins involved in IKK synthesis
[23]. There are three isoforms of IkB’s and oscillations are
observed only when IkBa is present while the others are knocked
out. Our simulations were for both wild as well as the knockout
type. Interestingly, oscillations in wild type situation were observed
when miRNAs target the adaptor proteins that are involved in
producing IKK. The miRNAs caused the biphasic behaviour in
the wild type to become oscillatory, with a subsequent decrease in
the amplitude and frequency of oscillations. In the knockout
system, the amplitude and frequency of oscillations that are
already present showed a decrease, suggesting that IKK is an
important entity in controlling the dynamics of NF-kB system.
This has also been seen in a number of experimental systems: for
instance Helicobacter pylori infection is controlled by miR-155 that
targets IKK directly [36].
Reduction in the level of IKK due to miRNAs results in the
decrease in NF-kB levels. Since in this scenario miRNAs are also
induced by NF-kB, their levels reduce when NF-kB levels fall,
causing IKK levels to increase. This in turn causes NF-kB levels to
rise. The involvement of miRNAs in a negative feedback loop
brings about the conversion from the characteristic biphasic to
oscillatory behaviour. On further reduction in the IKK levels as
miRNA levels are increased there is less activated NF-kB, and this
leads to a decrease in the frequency and amplitude of the
oscillations. In this case miRNAs act as negative regulators of the
pathway, ensuring that the immune response does not go out of
control.
In the second scenario, IkB’s were considered as targets for
miRNAs, an instance of which is the case of KSHV miRNAs that
Figure 5. Scenario 2. IKK frees NF-kB from inhibition by IkB. The
miRNA targets the inhibitors of NF-kB (IkB). The sign ‘‘+’’ indicates
activation whereas the sign ‘‘2’’ indicates repression.
doi:10.1371/journal.pone.0027774.g005
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target IkBa [27]. When IkBb or both IkBb and IkBe were
targeted by miRNAs the dynamics became oscillatory, but with an
increase in frequency and amplitude of oscillations as the rates of
miRNA participation increased. Thus here miRNAs act as positive
regulators of the pathway. This is somewhat similar to the studies
wherein the isoforms are knocked out by external aids; miRNAs
perform the same function naturally within the system.
All the three isoforms have different functions and IkBa is the one
responsible for the oscillations owing to the negative feedback loop it
is involved in. The other two forms play a role in masking these
oscillations. The role of IkBe is not clear since when it is targeted
there is no change at all, indicating that it may have an indirect role or
it may act only in combination with other isoforms IkBb and IkBa.
The results are consistent with earlier experimental findings.
IkBa is involved in a negative auto regulatory loop reducing the
activity of NF-kB. The reaction corresponding to this inducible
transcription is also the most important and sensitive of all the
reactions in the pathway, and therefore when only the IkBa
isoform is present and the other two are removed, the dynamics
becomes oscillatory. The importance of IkBa (4 out of the 7 cases)
is clear from the fact that when it is targeted the biphasic plot gets
distorted and the single peak is also removed (See Figure S5).
Thus, in this study we show that oscillations also result when
miRNAs are introduced in the system. Depending on the nature
and role of the target protein in the pathway, the effect of the
miRNA can be to enhance or attenuate NF-kB levels.
There are experimental observations that have verified the
involvement of miRNAs in these steps. miRNA induced oscillatory
behaviour can be a useful mechanism in controlling inflammatory
response induced by infection and other agents, as it helps to
dampen the response and contain infection. Uncontrolled
response can cause serious damage to the organism and miRNAs
can therefore serve to keep them in check. The models and results
presented here can be a basis of understanding inflammatory
response under different situations and help in developing better
therapeutics. Our study is consistent with the current understand-
ing of the NF-kB pathway. The approach used in this study can
also be useful in studying role of miRNAs in different regulatory
and control circuits.
Materials and Methods
We consider a model of the NF-kB pathway [9] that comprises
64 reactions and involves 24 species. miRNA related processes
Figure 6. Conversion from wild type to oscillatory type behaviour on incorporation of miRNA targeting only IkBb. A) Case 1 B) Case 2.
The colored lines in the figure represent the effect at varying levels of the three miRNA parameters. The parameter values in parenthesis are c1, c3, c4/
c5 respectively: Red (0.00, 0.000, 0.000), Green (0.01, 0.001, 0.001), Blue (0.03, 0.003, 0.003), Pink (0.05, 0.005, 0.005), Cyan (0.07, 0.007, 0.007), Yellow
(0.10, 0.010, 0.010). In the y-axis title ‘‘NF-kappaBn’’, the ‘‘n’’ stands for nuclear. The Quantification was done in terms of: C) Alteration in the frequency
D) Alteration in the height of the first peak. Figure sections C, D are derived from sections A, B. The x-axis signifies the 6 levels of variation of the three
parameters as given in sections A, B. The Brown and Black lines represent Cases 1 and 2 respectively.
doi:10.1371/journal.pone.0027774.g006
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were then included, and their time evolution was studied within a
deterministic formalism, namely by deriving the appropriate set of
coupled differential equations. Codes were written in C and Perl.
Parameters related to the miRNA regulation were chosen to
correspond to experimentally estimated rates. Since intracellular
miRNA steady state levels result from not only the synthesis of new
miRNAs but also the degradation of these miRNAs, characterisa-
tion of miRNA persistence is indispensable. For the miRNA
degradation rate the estimate given in a recent work by Khanin
and Vinciotti was used [37]. They developed a kinetic model of
post-transcriptional regulation by miRNAs that made an exper-
imentally verifiable prediction of miR-124a decay rate
(0.024 h21). This decay rate corresponds to a half-life of 29 h
with 95% confidence bounds (26 h, 50 h).
In a recent study [38] miRNA decay rates were measured in
Mouse embryonic fibroblasts following the loss of Dicer 1
enzymatic activity. The half-life was measured to be 21.6 h.
Intracellular miRNA levels were affected by dilution from cellular
division, and therefore to calculate the miRNA half-life,
independent of cellular division and any residual Dicer 1 activity,
the decay rates of a panel of six miRNAs were measured and a
mathematical model was established to predict miRNA stability in
a non-dividing cell population devoid of any Dicer activity. An
average miRNA half life was determined to be 119 h (5 days) [38].
Supporting Information
Figure S1 Qualitative effect of miRNA targeting the
IRAK1/TRAF6 complex in the wild type. When only c1 is
varied, keeping c3 at 0.001, c4/c5 at 0.001: A) Case 1 B) Case 2.
The colored lines in the figure represent the effect at varying levels
of the c1 parameter. The parameter value in the parenthesis is c1
only: Red (0.00), Green (0.01), Blue (0.05), Pink (0.10), Cyan
(0.50), and Yellow (1.00). When only c3 is varied, keeping c1 at
0.01, c4/c5 at 0.001: C) Case 1 D) Case 2. The colored lines in the
figure represent the effect at varying levels of the c3 parameter.
The parameter value in the parenthesis is c3 only: Red (0.000),
Green (0.001), Blue (0.003), Pink (0.005), Cyan (0.007), and Yellow
(0.010). When only c4 and c5 are varied in Case 1 and Case 2
respectively, keeping c1 at 0.01, c3 at 0.01: E) Case 1 F) Case 2.
The colored lines in the figure represent the effect at varying levels
of the c4/c5 parameter. The parameter value in parenthesis is c4/
Figure 7. Conversion from wild type to oscillatory type behaviour on incorporation of miRNA targeting both IkBb and IkBe. A) Case 1
B) Case 2. The colored lines in the figure represent the effect at varying levels of the three miRNA parameters. The parameter values in parenthesis are
c1, c3, c4/c5 respectively: Red (0.00, 0.000, 0.0000), Green (0.01, 0.001, 0.0001), Blue (0.03, 0.003, 0.0003), Pink (0.05, 0.005, 0.0005), Cyan (0.07, 0.007,
0.0007), Yellow (0.10, 0.010, 0.0010). In the y-axis title ‘‘NF-kappaBn’’, the ‘‘n’’ stands for nuclear. The Quantification was done in terms of: C) Alteration
in the frequency D) Alteration in the height of the first peak. Figure sections C, D are derived from sections A, B. The x-axis signifies the 6 levels of
variation of the three parameters as given in sections A, B. The Brown and Black lines represent Cases 1 and 2 respectively.
doi:10.1371/journal.pone.0027774.g007
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c5 only: Red (0.000), Green (0.001), Blue (0.003), Pink (0.005),
Cyan (0.007), and Yellow (0.010). In the y-axis title ‘‘NF-
kappaBn’’, the ‘‘n’’ stands for nuclear.
(TIFF)
Figure S2 Quantification of the effect of miRNA,
targeting the IRAK1/TRAF6 complex in the wild type.
Quantification was done in terms of alteration in the height of the
first peak. A) When only c1 is varied. B) When only c3 is varied. C)
When only c4 and c5 are varied in Case 1 and Case 2 respectively.
The x-axis signifies the variation of the parameter individually,
keeping the other two constant as given in S 1. The Brown and
Black lines represent Cases 1 and 2 respectively.
(TIFF)
Figure S3 Qualitative effect of miRNA targeting the
IRAK1/TRAF6 complex in the knockout type. When only
c1 is varied, keeping c3 at 0.001, c4/c5 at 0.001: A) Case 1 B) Case
2. The colored lines in the figure represent the effect at varying
levels of the c1 parameter. The parameter value in the parenthesis
is c1 only: Red (0.00), Green (0.01), Blue (0.05), Pink (0.10), Cyan
(0.50), and Yellow (1.00). When only c3 is varied, keeping c1 at
0.01, c4/c5 at 0.001: C) Case 1 D) Case 2. The colored lines in the
figure represent the effect at varying levels of the c3 parameter.
The parameter value in the parenthesis is c3 only: Red (0.000),
Green (0.001), Blue (0.003), Pink (0.005), Cyan (0.007), and Yellow
(0.010). When only c4 and c5 are varied in Case 1 and Case 2
respectively, keeping c1 at 0.01, c3 at 0.01: E) Case 1 F) Case 2.
The colored lines in the figure represent the effect at varying levels
of the c4/c5 parameter. The parameter value in parenthesis is c4/
c5 only: Red (0.000), Green (0.001), Blue (0.003), Pink (0.005),
Cyan (0.007), and Yellow (0.010). In the y-axis title ‘‘NF-
kappaBn’’, the ‘‘n’’ stands for nuclear.
(TIFF)
Figure S4 Quantification of the effect of miRNA target-
ing the IRAK1/TRAF6 complex in the knockout type.
When only c1 is varied: A) In terms of alteration in frequency B) In
terms of alteration in the height of the first peak. When only c3 is
varied: C) In terms of alteration in frequency D) In terms of
alteration in the height of the first peak. When only c4 and c5 are
varied in Case 1 and Case 2 respectively: E) In terms of alteration
in frequency F) In terms of alteration in the height of the first peak.
The x-axis signifies the variation of the parameter individually,
keeping the other two constant as given in S 3. The Brown and
Black lines represent Cases 1 and 2 respectively.
(TIFF)
Figure S5 The biphasic plot gets distorted when the
miRNA target is: Only IkBa: A) Case 1 B) Case 2. Only IkBe:
C) Case 1 D) Case 2. Both IkBa and IkBb: E) Case 1 F) Case 2.
Both IkBa and IkBe: G) Case 1 H) Case 2. All the three IkB’s
(IkBa, IkBb, IkBe): I) Case 1 J) Case 2. In the y-axis title ‘‘NF-
kappaBn’’, the ‘‘n’’ stands for nuclear.
(TIFF)
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